Literature DB >> 15616838

High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil.

C A Blal1, S R L Passos, C Horn, I Georg, M G Bonecini-Almeida, V C Rolla, L De Castro.   

Abstract

To determine the prevalence and exposure factors associated with hepatitis B infection in tuberculosis patients with and without HIV type 1 coinfection, the presence of hepatitis B virus serological markers was investigated in a retrospective study. The seroprevalence of hepatitis B virus in patients with tuberculosis only was 14.6%, and in tuberculosis patients coinfected with HIV it increased to 35.8%. In patients with HIV and tuberculosis coinfection, homosexuality constituted the principal exposure factor, while in tuberculosis patients without HIV, a gradual increase in hepatitis B virus seroprevalence was noted along with increasing age. The results demonstrate that hepatitis B infection is highly prevalent in tuberculosis patients in Brazil and suggest that a vaccination program for the general population should be considered in order to prevent further hepatitis B infections.

Entities:  

Mesh:

Year:  2005        PMID: 15616838     DOI: 10.1007/s10096-004-1272-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

Review 1.  Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity.

Authors:  C M Martelli; M Turchi; F J Souto; A Sáez-Alquézar; A L Andrade; F Zicker
Journal:  Rev Panam Salud Publica       Date:  1999-07

2.  Hepatitis B epidemiology in Latin America.

Authors:  J Tanaka
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

3.  Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status.

Authors:  M F Cantwell; M T McKenna; E McCray; I M Onorato
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

4.  Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection.

Authors:  W M Wong; P C Wu; M F Yuen; C C Cheng; W W Yew; P C Wong; C M Tam; C C Leung; C L Lai
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

5.  Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Authors:  Mark S Sulkowski; David L Thomas; Shruti H Mehta; Richard E Chaisson; Richard D Moore
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

6.  Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection.

Authors:  Antonio Aceti; Caterina Pasquazzi; Barbara Zechini; Carlo De Bac
Journal:  J Acquir Immune Defic Syndr       Date:  2002-01-01       Impact factor: 3.731

7.  Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centres.

Authors:  Niels Fisker; Jørgen Georgsen; Torsten Stolborg; Mohammed Rohi Khalil; Peer Brehm Christensen
Journal:  J Med Virol       Date:  2002-12       Impact factor: 2.327

Review 8.  Hepatitis B: an important public health issue.

Authors:  W C Maddrey
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

9.  Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent.

Authors:  Annemiek A van der Eijk; Hubert G M Niesters; Hannelore M Götz; Harry L A Janssen; Solko W Schalm; Albert D M E Osterhaus; Robert A de Man
Journal:  J Clin Virol       Date:  2004-02       Impact factor: 3.168

10.  Horizontal transmission of hepatitis B virus.

Authors:  P Van Damme; M Cramm; J C Van der Auwera; R Vranckx; A Meheus
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

View more
  4 in total

1.  Viral hepatitis prevalence in patients with active and latent tuberculosis.

Authors:  Hesam Ahmadi Nooredinvand; David W Connell; Mahmoud Asgheddi; Mohammed Abdullah; Marie O'Donoghue; Louise Campbell; Melissa I Wickremasinghe; Ajit Lalvani; Onn Min Kon; Shahid A Khan
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

2.  Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India.

Authors:  Parnita Harsh; Vipin Gupta; Saurabh Kedia; Sawan Bopanna; Sucharita Pilli; Govind Kumar Makharia; Vineet Ahuja
Journal:  Intest Res       Date:  2017-01-31

Review 3.  Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Authors:  Elizabeth Whittaker; Elisa López-Varela; Claire Broderick; James A Seddon
Journal:  Front Pediatr       Date:  2019-06-25       Impact factor: 3.418

4.  Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

Authors:  Amy S Nunn; Elize M Fonseca; Francisco I Bastos; Sofia Gruskin; Joshua A Salomon
Journal:  PLoS Med       Date:  2007-11-13       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.